FHC
WST icon

First Heartland Consultants’s West Pharmaceutical WST Stock Holding History

First Heartland Consultants’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-558
Closed -$200K – 626
2026
Q2 		$200K Buy
+558
New +$171K 0.01% 576

Other funds holding WST

BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
BWM
Biltmore Wealth Management Tempe, Arizona $323M AUM 13.82% 1-Year Est. Return
RFA
RTD Financial Advisors Philadelphia, Pennsylvania $914M AUM 11.18% 1-Year Est. Return

First Heartland Consultants's WST Position: Q3 2026 in Review

First Heartland Consultants sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 558 shares — an estimated $200K sold.

First Heartland Consultants first reported a position in WST in Q2 2026 and held it in 1 quarter. The position peaked at $200K in Q2 2026. 29 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • First Heartland Consultants reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • First Heartland Consultants sold 558 West Pharmaceutical shares in Q3 2026, an estimated $200K.
  • First Heartland Consultants first reported a position in West Pharmaceutical in Q2 2026 and held it in 1 quarter.
  • First Heartland Consultants's West Pharmaceutical position peaked at $200K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on First Heartland Consultants's 13F filing for Q3 2026, filed 8 Oct 2026.